Loading...
Loading...
In a report published Friday, Jefferies analyst Randal J. Konik reiterated a Hold rating on Body Central Corp.
BODY, and slightly raised the price target from $8.00 to $9.00.
In the report, Konik noted, “BODY reported soft 1Q numbers, as expected, but we don't think it really matters as the company has a new management team in place, lowered expectations and most importantly has a very strong balance sheet (~25% of market cap). We think it will be some time before the stock potentially moves higher but see a lot of the bad news as already baked in at current levels. Reiterate Hold.”
Body Central Corp. closed on Thursday at $10.28.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in